August 01, 2017 article Open access The PI3K Pathway in Human Disease Cell DOI: 10.1016/j.cell.2017.07.029 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 10 stored of 2,823 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Associations Between Short‐Term Changes in Disease Activity and Long‐Term Clinical Outcomes in Activated Phosphoinositide 3‐Kinase Delta Syndrome 2026 Journal of Immunology Research article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access 0 citations Natural history of clinical manifestations in activated phosphoinositide 3-kinase δ syndrome (APDS): Time-to-event analyses using the European Society for Immunodeficiencies-APDS registry 2025 Clinical Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access 3 citations Reversion of aortic valve cells calcification by activation of Notch signalling via histone acetylation induction 2025 Signal Transduction and Targeted Therapy article Medicine Cardiac Valve Diseases and Treatments Open access 4 citations Systematic literature reviews to identify epidemiological, clinical, economic and health-related quality of life evidence in activated PI3Kδ syndrome (APDS) 2025 BMC Immunology review Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access 1 citations Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA) 2025 Global & Regional Health Technology Assessment article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access 2 citations Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): an externally controlled study 2024 Clinical & Experimental Immunology article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access 7 citations European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection 2024 Neuro-Oncology article Medicine Meningioma and schwannoma management Open access 38 citations Farnesol Inhibits PI3 Kinase Signaling and Inflammatory Gene Expression in Primary Human Renal Epithelial Cells 2023 Biomedicines article Medicine Natural Compounds in Disease Treatment Open access 2 citations PI3Kδ Pathway Dysregulation and Unique Features of Its Inhibition by Leniolisib in Activated PI3Kδ Syndrome and Beyond 2023 The Journal of Allergy and Clinical Immunology In Practice article Immunology and Microbiology Immunodeficiency and Autoimmune Disorders Open access 27 citations Functional evidence (II) protein and enzyme function 2021 Elsevier eBooks book-chapter Biochemistry, Genetics and Molecular Biology Genomics and Rare Diseases 1 citations 10 results References 0